arrow
V

Virginia Wiseman

Kirby Institute
H指数:37
被引数:4,339

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A universal approach to reducing stigma in healthcare: a program logic for The Stigma-Free Standard

一种减少医疗保健领域耻感污名的方法:针对《无耻感标准》的项目逻辑

2026-10-090
OAAI
Assessing the impact of the COVID-19 pandemic on uptake of HIV treatment in Bandung and Yogyakarta, Indonesia: A retrospective cohort study

评估COVID-19疫情对印度尼西亚万隆和日惹地区HIV治疗接受度的影响:一项回顾性队列研究

2025-12-230
PRE
Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets

谁在性健康和生殖健康方面支付费用,什么措施能带来回报?对干预措施的成本和成本效益的回顾,以及对未来资金和市场的启示

2025-10-300
PRE
Understanding the financial hardships faced by TB and HIV patients during the COVID-19 pandemic: a mixed-method study in Bandung and Yogyakarta, Indonesia

理解COVID-19疫情期间结核病和艾滋病患者在万隆和印度尼西亚日惹所面临的财务困难:一项混合方法研究

2025-10-010
PRE
Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention: a pragmatic randomised controlled trial in Pakistan
2025-01-150
OAAI
The impact of a multi-faceted intervention on non-prescription dispensing of antibiotics by urban community pharmacies in Indonesia: a mixed methods evaluation
2024-10-040
OAAI
Cost and cost-effectiveness analysis of mass drug administration compared to school-based targeted preventive chemotherapy for hookworm control in Dak Lak province, Vietnam

越南Dak Lak省的大规模药物管理与基于学校的针对性预防性化学疗法控制钩虫的成本和成本效益分析

2023-12-012
OAAI
Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment
2022-06-017
PRE